FBC方案预处理进行异基因造血干细胞移植的临床研究
被引量:2
摘要
造血干细胞移植对根治恶性血液病的作用已得到充分肯定,但传统预处理方案所用的致死性放、化疗剂量对患者心、肝、肾等重要脏器有进一步损伤,致使移植相关死亡率一直居高不下 [1].为降低预处理的毒性,我们对14例恶性血液病患者进行了FBC预处理方案的异基因造血干细胞移植.
出处
《中国肿瘤生物治疗杂志》
CAS
CSCD
2005年第2期150-151,共2页
Chinese Journal of Cancer Biotherapy
参考文献3
-
1王玫,韩明哲,冯四洲,李成文,邱录贵,姜容,邹德慧,阎石,杨丛林,韩忠朝,严文伟.异基因外周血干细胞移植和异基因骨髓移植的临床疗效比较[J].中华血液学杂志,1999,20(8):427-430. 被引量:14
-
2Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alterative to conventional bone marrow transplantation with lethal cytoreductive for treatment of malignant and nonmalignant hematologic disease[J]. Blood, 1998, 91(3): 756-763.
-
3刘启发,周淑芸.供者淋巴细胞输注对异基因造血干细胞移植后白血病复发的防治作用[J].中华血液学杂志,2002,23(4):220-222. 被引量:11
二级参考文献11
-
1张之南,血液病诊断及疗效标准(第2版),1998年,36页
-
2Cchleuning M.Adoptive allogeneic immunotherapy-history and future perspectives[].Transfusion Science.2000
-
3van Rhee F,Savage D,Blackwell J,et al.Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant : equal efficacy of lymphocyte from sibling and matched unrelated donors[].Bone Marrow Transplantation.1998
-
4Mackinnon S,Papadopoulos EB,Carabasi MH,et al.Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease[].Blood.1995
-
5Georges GE,Storb R,Thompson JD,et al.Adoptive immunotherapy in canine mixed chimerase after nonmyeloablative hematopoietic cell transplantation[].Blood.2000
-
6Colby C,Sykes M,Sachs DH,et al.Cellular modulation of acute graftvs-host disease[].Biology of Blood and Marrow Transplantation.1997
-
7Bordignon C,Carlo-Stella C,Colombo MP,et al.Cell therapy: achievement and perspectives[].Haematologica.1999
-
8Bishop MR,Tarantolo SR,Pavletic ZS,et al.Filgrastim as an alternative to donor leukocyte infusion for relapse after allogeneic stem-cell transplantation[].Journal of Clinical Oncology.2000
-
9Dazzi F,Szydlo RM,Craddock C,et al.Comparison of single-dose and escalating-dose regimems of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia[].Blood.2000
-
10Wu CJ,Yang XF,Mclaughlin S,et al.detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia[].The Journal of Clinical Investigation.2000
共引文献22
-
1王玫,冯四洲,魏嘉璘,杨栋林,王荷花,梁晓岚,周征,周世勇,翟文静,韩明哲.HLA表型对异基因造血干细胞移植后急性移植物抗宿主病影响的研究[J].山东医药,2004,44(20):7-9.
-
2黄宁,葛林阜,马焕文,刘希民,郭鹏.异基因造血干细胞移植FBC预处理14例[J].肿瘤学杂志,2004,10(6):393-394. 被引量:2
-
3白萍,李莉,万理萍,王椿.外周血干细胞移植后造血重建的规律及相关因素分析[J].上海医学,2005,28(5):396-398.
-
4黄宁,葛林阜,刘希民,马焕文,孔立新,郭鹏.造血干细胞移植治疗难治性血液病临床研究(附117例报告)[J].山东医药,2005,45(16):1-3. 被引量:9
-
5何祎,王荷花,梁晓岚,冯四洲,王玫,韩明哲.KIR配体不合在主要组织相容性复合物不合造血干细胞移植中的作用[J].中华内科杂志,2006,45(8):668-669. 被引量:1
-
6袁成录,李颖,史春雷,王玲.异基因造血干细胞移植治疗恶性血液病的效果[J].青岛大学医学院学报,2006,42(4):341-344. 被引量:3
-
7樊晓丽.干细胞研究进展(综述)[J].中国城乡企业卫生,2007,22(1):41-44. 被引量:4
-
8黄宁,葛林阜,姜夕锋,刘希民,郭鹏,周芳.非血缘异基因脐血移植治疗SAA可行性研究[J].山东医药,2007,47(4):7-8.
-
9王存邦,白海,欧英贤,潘耀柱,张茜,葸瑞.混合造血干细胞移植后输注供者淋巴细胞和白细胞介素2对急性髓性白血病疗效的影响[J].中国组织工程研究与临床康复,2007,11(24):4777-4780. 被引量:4
-
10王华,何祎,王荷花,王玫,翟文静,周征,张荣莉,翟卫华,冯四洲,韩明哲.供者活化型KIR2DS5在单倍体相合造血干细胞移植预后中的意义[J].中国实验血液学杂志,2008,16(1):111-115. 被引量:3
同被引文献24
-
1Zelenetz AD,Abramson JS,Advani RH,et al.Non-Hodgkin′sLymphomas[J].J Natl Compr Canc Netw,2011,9(5):484-560.
-
2Peniket AJ,Ruiz de Elvira MC,Taghipour G,et al.An EBMTregistry matched study of allogeneic stem cell transplants forlymphoma:allogeneic transplantation is associated with a lowerrelapse rate but a higher procedure-related mortality rate thanautologous transplantation[J].Bone Marrow Transplantation,2003,31(8),667-678.
-
3Slavin S,Nagler A,Naparstek E,et al.Nonmyeloablative stemcell transplantation and cell therapy as an alternative toconventional bone marrow transplantation with lethalcytoreduction for the treatment of malignant and nonmalignanthematologic diseases[J].Blood,1998,91(3):756-763.
-
4Bloor AJ,Thomson K,Chowdhry N,et al.High response rateto donor lymphocyte infusion after allogeneic stem celltransplantation for indolent non-Hodgkin lymphoma[J].BiolBlood Marrow Transplant,2008,14(1):50-58.
-
5Calvo-Villas JM,Martin A,Conde E,et al.Effect of addition ofrituximab to salvage chemotherapy on outcome of patients withdiffuse large B-cell lymphoma relapsing after an autologousstem-cell transplantation[J].Ann Oncol,2010,21(9):1891-1897.
-
6Gisselbrecht C,Glass B,Mounier N,et al.Salvage regimenswith autologous transplantation for relapsed large B-celllymphoma in the rituximab era[J].Ann Oncol,2010,28(27):4184-4190.
-
7Thomson KJ, Peggs KS, Smith P, et al. Superiority of reduced- intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation. Bone Marrow Transplant, 2008, 41 : 765-770.
-
8Sorror ML, Storer BE, Maloney DG, et al. Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia. Blood, 2008, 111 : 446-452.
-
9le Blanc K, Remberger M, Uzunel M, et al. A comparison of nnnmyeloablai''e and reduced-intensity conditioning for allogeneic stem-cell transplantation. Transplantation, 2004, 78:1014-1020.
-
10Kuruvilla J, Keating A, Crump M. How I treat relapsed and refractory Hedgkin lymphoma. Blox/d, 2011, 117:4208-4217.
引证文献2
-
1苏毅,易海,付利,范方毅,孙浩平,刘阳阳,邓涛,王译,何光翠,赖思含,王淋,刘一岚.异基因造血干细胞移植治疗自体造血干细胞移植后复发的非霍奇金淋巴瘤临床观察[J].华西医学,2011,26(12):1780-1782. 被引量:1
-
2易海,苏毅,付利,范方毅,孙浩平,王译,何光翠,赖思含.异基因造血干细胞移植治疗自体造血干细胞移植后复发的霍奇金淋巴瘤四例[J].白血病.淋巴瘤,2013,22(11):690-691.
-
1本刊可直接使用缩写的常用词汇[J].广西医学,2009,31(7):1007-1007.
-
2黄宁,葛林阜,马焕文,刘希民,郭鹏.异基因造血干细胞移植FBC预处理14例[J].肿瘤学杂志,2004,10(6):393-394. 被引量:2
-
3本刊可直接使用缩写的常用词汇[J].广西医学,2009,31(11):1701-1701.
-
4袁年粉.护理干预在急性重症胰腺炎患者中的应用及预后评价[J].齐鲁护理杂志,2013,19(23):85-86. 被引量:8
-
5周兰月,张东红,尹玲,解丹.FBC预处理方案进行异基因造血干细胞移植的护理[J].山东医药,2006,46(4):83-83.
-
6于风格,李萍.糖尿病病人的心理特点及护理[J].中国保健营养(下半月),2010(6):189-190.
-
7王晶,谷元廷,李林,朱明智.37例男性乳腺癌患者临床特征及预后分析[J].第三军医大学学报,2014,36(12):1335-1337. 被引量:4
-
8于洪艳,吴永芝,孙英莉,杨玲,刘海军,王莉莉.CAEA预处理自体骨髓移植治疗急性非淋巴细胞白血病6例(附文献复习)[J].江西医药,2005,40(3):152-154.
-
9冯金霞.综合护理干预对糖尿病患者的疗效分析[J].糖尿病新世界,2016,19(14):193-194.
-
10赵利东,王莹,刘惠杰,蔡志梅,杨建峰,朱学涛,刘波.异基因造血干细胞移植治疗恶性血液病[J].白血病.淋巴瘤,2007,16(1):60-61. 被引量:1